These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 823307)

  • 1. Treatment of experiment delayed cerebral arterial spasm with a beta2-adrenergic stimulator and a phosphodiesterase inhibitor.
    Norwood CW; Poole J; Moody D
    J Neurosurg; 1976 Nov; 45(5):491-7. PubMed ID: 823307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental cerebral vasospasm and cyclic adenosine monophosphate (c-AMP).
    Kim J; Flamm ES; Lin J
    Invest Radiol; 1975; 10(3):239-43. PubMed ID: 166052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model.
    Varsos VG; Liszczak TM; Han DH; Kistler JP; Vielma J; Black PM; Heros RC; Zervas NT
    J Neurosurg; 1983 Jan; 58(1):11-7. PubMed ID: 6847896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral arterial spasm. II. Etiology and treatment of experimental cerebral vasospasm.
    Morooka H
    Acta Med Okayama; 1978 Apr; 32(1):39-49. PubMed ID: 207156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase inhibitors and cerebral vasospasm.
    Flamm ES; Kim J; Lin J; Ransohoff J
    Arch Neurol; 1975 Aug; 32(8):569-71. PubMed ID: 168844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Successful treatment of delayed arterial spasm in the rhesus monkey after subarachnoid haemorrhage.
    Norwood CW; Poole GJ; Moody D; Alexander E
    J Neurol Neurosurg Psychiatry; 1975 Apr; 38(4):404. PubMed ID: 237988
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cerebral vasospasm. The cerebral arterial spasm of subarachnoid hemorrhage--a new hemodynamic dimension].
    Pendefunda L; Georgescu EM
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(4):649-54. PubMed ID: 3253916
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiological considerations important for the management of vasospasm.
    Sundt TM; Szurszewski J; Sharbrough FW
    Surg Neurol; 1977 May; 7(5):259-67. PubMed ID: 324008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of intravenous aminophylline and salbutamol in the treatment of severe bronchospasm.
    Beswick K; Davies J; Davey AJ
    Practitioner; 1975 Apr; 214(1282):561-566. PubMed ID: 1096127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminophylline plus nitroprusside and dopamine for treatment of cerebral vasospasm. A preliminary report.
    Levy WJ; Bay JW; Sawhny B; Tank T
    J Neurosurg; 1982 May; 56(5):646-9. PubMed ID: 7069476
    [No Abstract]   [Full Text] [Related]  

  • 11. Additive interaction of aminophylline and salbutamol in asthma: an in vivo study using dose-response curves.
    Leopold D; Handslip P
    J Int Med Res; 1979; 7 Suppl 1():52-5. PubMed ID: 374165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition.
    Gavras H; Andrews P; Papadakis N
    J Neurosurg; 1981 Dec; 55(6):884-8. PubMed ID: 6170740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cerebral vasospasm by control of cyclic adenosine monophosphate.
    Flamm ES; Ransohoff J
    Surg Neurol; 1976 Oct; 6(4):223-6. PubMed ID: 184555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminophylline and isoproterenol in the treatment of cerebral vasopasm.
    Fleischer AS; Raggio JF; Tindall GT
    Surg Neurol; 1977 Aug; 8(2):117-21. PubMed ID: 888087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase inhibitors and cerebral vasospasm.
    Flamm ES; Kim J; Lin J; Ransohoff J
    Trans Am Neurol Assoc; 1974; 99():137-40. PubMed ID: 4377047
    [No Abstract]   [Full Text] [Related]  

  • 16. A primate model of chronic cerebral vasospasm.
    Frazee JG
    Stroke; 1982; 13(5):612-4. PubMed ID: 7123592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of vagal input on cerebral blood flow in monkeys and dogs after experimental cerebral vasospasm.
    Ryba M; Głowicki K; Zalewski W; Januszewski S; Kukwa A
    Acta Neurobiol Exp (Wars); 1985; 45(5-6):163-71. PubMed ID: 4096279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of medical treatment (isoproterenol + aminophylline) of aneurysm rupture spasm].
    George B; Muzard O; Begue T; Roux FX; Goldstein A; Ragueneau JL
    Neurochirurgie; 1984; 30(4):273-6. PubMed ID: 6472552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental subarachnoid hemorrhage-induced intracranial arterial vasonecrosis with phosphodiesterase inhibitor phthalazinol (EG-626).
    Alksne JF; Branson PJ
    Stroke; 1979; 10(6):638-44. PubMed ID: 118551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of nimodipine for prevention and treatment of cerebral arterial spasm in patients with subarachnoid hemorrhage.
    Welty TE
    Clin Pharm; 1987 Dec; 6(12):940-6. PubMed ID: 3322639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.